Cell

Biotech's perfect storm.

S Karberg

The global financial crisis has hit biotech companies hard both in the US and Europe as venture capital dries up. Finding new sources of long-term financing for translating research into new therapeutics will be essential for maintaining innovation and new drug development by biotech companies.

-Biotechnology (+economics; -trends)
-Capital Financing
-Europe
-Health Care Costs
-United States

pii:S0092-8674(09)00905-2
doi:10.1016/j.cell.2009.07.026
pubmed:19665960

